Hydrocortison Strides Pharma (Cyprus) Limited (Hydrocortisone)

Hydrocortison Strides Pharma is indicated for several clinical situations where glucocorticoid therapy is required.

• Adrenal insufficiency (primary or secondary) requiring cortisol replacement.
• Acute exacerbations of inflammatory conditions such as rheumatoid arthritis.
• Management of severe allergic reactions when oral therapy is appropriate.
• Treatment of autoimmune disorders like systemic lupus erythematosus.
• Replacement therapy in patients with congenital adrenal hyperplasia.
• Supportive care in certain dermatologic conditions where systemic therapy is needed.

• Hydrocortison Strides Pharma delivers hydrocortisone, a synthetic analogue of endogenous cortisol. The compound binds to intracellular glucocorticoid receptors, forming a receptor‑ligand complex that translocates to the nucleus. This complex interacts with glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins and suppressing pro‑inflammatory cytokine production. The net effect reduces inflammation, stabilizes lysosomal membranes, decreases immune cell activation, and improves vascular tone.

Oral hydrocortisone may cause a range of adverse reactions, varying from mild to severe.

Common

• Increased appetite or weight gain.
• Mild gastrointestinal discomfort such as nausea.
• Fluid retention leading to mild swelling.
• Mood changes including irritability or mild insomnia.

Serious

• Severe hyperglycemia or new‑onset diabetes.
• Significant hypertension or cardiovascular events.
• Suppression of the hypothalamic‑pituitary‑adrenal (HPA) axis causing adrenal crisis.

Before initiating Hydrocortison Strides Pharma, several precautionary measures should be considered.

• Assess for active infections; glucocorticoids can worsen bacterial, viral, or fungal infections.
• Evaluate blood glucose levels in diabetic or at‑risk patients.
• Monitor blood pressure regularly, especially in patients with cardiovascular disease.
• Use the lowest effective dose for the shortest duration to limit systemic effects.
• Consider bone health; long‑term use may increase risk of osteoporosis.
• Review any history of psychiatric disorders, as steroids can affect mood.
• Avoid abrupt discontinuation; tapering is required to prevent adrenal insufficiency.

Hydrocortison Strides Pharma can interact with other medicines, influencing efficacy or safety.

Avoid

• Strong CYP3A4 inducers such as rifampin, which may reduce hydrocortisone levels.
• Concurrent use of systemic anticoagulants, which may increase bleeding risk.
• High‑dose NSAIDs, which can raise the risk of gastrointestinal ulceration.

Use with caution

• Antidiabetic agents, as glucocorticoids may raise blood glucose.
• Antihypertensive drugs, because fluid retention can counteract blood pressure control.
• Vaccines, particularly live attenuated vaccines, due to immunosuppression.